News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cellceutix Signs Agreement with Girindus for Kevetrin(tm) API


8/17/2009 10:07:47 AM

BEVERLY, Mass., Aug. 17, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX), a bio-pharmaceutical company in the business of developing small-molecule therapies in areas of unmet medical needs, today announced that it has signed an agreement with Girindus America, Inc., for the manufacture of Kevetrin active pharmaceutical ingredient. Terms of the agreement were not disclosed.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES